All Stories

  1. Comparison Between Varicocelectomy and Varicocele Sclerotherapy: Results of a Single-Center Observational Study
  2. Incidental Parathyroidectomy After Thyroid Surgery: A Single-Center Study
  3. Effects of Switching FSH Preparations on Sperm Parameters and Pregnancy: A Prospective Controlled Study
  4. New insights of target therapy: Effects of tyrosine kinase inhibitors on male gonadal function: A systematic review
  5. Body Image and Other Mood Vulnerabilities in Adolescents with Polycystic Ovary Syndrome and Metabolic Alterations
  6. In-Vitro Effects of Perfluorooctanoic Acid on Human Sperm Function: What Are the Clinical Consequences?
  7. Impact of COVID-19 on testicular function: a systematic review and meta-analysis
  8. Oxidative stress affects sperm health and fertility—Time to apply facts learned at the bench to help the patient: Lessons for busy clinicians
  9. Effects of Varicocele Repair on Testicular Endocrine Function: A Systematic Review and Meta-Analysis
  10. The Role of Irisin throughout Women’s Life Span
  11. Alpha-Lipoic Acid Reduces Cell Growth, Inhibits Autophagy, and Counteracts Prostate Cancer Cell Migration and Invasion: Evidence from In Vitro Studies
  12. Relationship between Iron Deficiency and Thyroid Function: A Systematic Review and Meta-Analysis
  13. Relationship between degree of methylation of sperm long interspersed nuclear element-1 (LINE-1) gene and alteration of sperm parameters and age: a meta-regression analysis
  14. Investigational follicle-stimulating hormone receptor agonists for male infertility therapy
  15. Anti-Dyslipidemic and Anti-Diabetic Properties of Corosolic Acid: A Narrative Review
  16. Impact of COVID-19 on Fetal Outcomes in Pregnant Women: A Systematic Review and Meta-Analysis
  17. Insulin-like Growth Factor 1, Growth Hormone, and Anti-Müllerian Hormone Receptors Are Differentially Expressed during GnRH Neuron Development
  18. Red Wine and Sexual Function in Men: An Original Point of View
  19. Mechanisms Suggesting a Relationship between Vitamin D and Erectile Dysfunction: An Overview
  20. Productivity Index in Clinical Andrology: Research Directions on High-Impact Topics and in Particular on Male Infertility
  21. Genetic Analysis of Patients with Congenital Hypogonadotropic Hypogonadism: A Case Series
  22. H19 Sperm Methylation in Male Infertility: A Systematic Review and Meta-Analysis
  23. Effects of Follicle-Stimulating Hormone on Human Sperm Motility In Vitro
  24. The Impact of a Very Short Abstinence Period on Assisted Reproductive Technique Outcomes: A Systematic Review and Meta-Analysis
  25. Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
  26. Assisted Reproductive Technology without Embryo Discarding or Freezing in Women ≥40 Years: A 5-Year Retrospective Study at a Single Center in Italy
  27. The Renaissance of Male Infertility Management in the Golden Age of Andrology
  28. Is It Time for Andrology and Endocrinology Professionals in Assisted Reproduction Centers?
  29. Artificial Intelligence in Andrology: From Semen Analysis to Image Diagnostics
  30. Sperm Mesoderm Specific Transcript Gene Methylation Status in Infertile Patients: A Systematic Review and Meta-Analysis
  31. Reply to Ducreux, B.; Fauque, P. Comment on “Cannarella et al. DNA Methylation in Offspring Conceived after Assisted Reproductive Techniques: A Systematic Review and Meta-Analysis. J. Clin. Med. 2022, 11, 5056”
  32. The Impact of a Very Short Abstinence Period on Conventional Sperm Parameters and Sperm DNA Fragmentation: A Systematic Review and Meta-Analysis
  33. The IGF1/FSH Ratio Correlates with Sperm Count and Testicular Volume
  34. Does the Ketogenic Diet Improve the Quality of Ovarian Function in Obese Women?
  35. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: An overview on male genital tract ultrasound reference ranges
  36. Resistance to Thyroid Hormones: A Case-Series Study
  37. Effects of Slow-Acting Metformin Treatment on the Hormonal and Morphological Thyroid Profile in Patients with Insulin Resistance
  38. The Possible Role of SARS-CoV-2 in Male Fertility: A Narrative Review
  39. DNA Methylation in Offspring Conceived after Assisted Reproductive Techniques: A Systematic Review and Meta-Analysis
  40. The Use of Ellagic Acid and Annona Muricata Improves Semen Quality in Men with High-Risk Papillomavirus Infection
  41. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate‐vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics
  42. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA
  43. Physical Examination for Endocrine Diseases: Does It Still Play a Role?
  44. Advances in non-hormonal pharmacotherapy for the treatment of male infertility: the role of inositols
  45. Relationship between Varicocele and Male Hypogonadism: A Review with Meta-Analysis
  46. Is Chronic Varicocele a Risk Factor for Secondary Hyperparathyroidism?
  47. Obesity and Male Reproduction: Do Sirtuins Play a Role?
  48. Impact of seminal low-risk human papillomavirus infection on sperm parameters of adult men
  49. Analysis of 29 Targeted Genes for Non-Obstructive Azoospermia: The Relationship between Genetic Testing and Testicular Histology
  50. Globozoospermia: A Case Report and Systematic Review of Literature
  51. Molecular Mechanisms Underlying the Relationship between Obesity and Male Infertility
  52. Complete Androgen Insensitivity Syndrome: From the Relevance of an Accurate Genetic Diagnosis to the Challenge of Clinical Management. A Case Report
  53. Does a Very Short Length of Abstinence Improve Assisted Reproductive Technique Outcomes in Infertile Patients with Severe Oligo-Asthenozoospermia?
  54. Erectile Dysfunction in Diabetic Patients: From Etiology to Management
  55. Effects of Selenium Supplementation on Sperm Parameters and DNA-Fragmentation Rate in Patients with Chronic Autoimmune Thyroiditis
  56. Retrospective Monocentric Clinical Study on Male Infertility: Comparison between Two Different Therapeutic Schemes Using Follicle-Stimulating Hormone
  57. Relevance of sperm imprinted gene methylation on assisted reproductive technique outcomes and pregnancy loss: a systematic review
  58. Coenzyme Q10, oxidative stress markers, and sperm DNA damage in men with idiopathic oligoasthenoteratospermia
  59. Ultrasound aspects of symptomatic versus asymptomatic forms of male accessory gland inflammation
  60. Is there a role for glucagon‐like peptide‐1 receptor agonists in the treatment of male infertility?
  61. Ultrasound evaluation of patients with male accessory gland inflammation: a pictorial review
  62. The Role of Resveratrol in Human Male Fertility
  63. The Role of Resveratrol Administration in Human Obesity
  64. Temporal Trend of Conventional Sperm Parameters in a Sicilian Population in the Decade 2011–2020
  65. Anti-Müllerian Hormone, Growth Hormone, and Insulin-Like Growth Factor 1 Modulate the Migratory and Secretory Patterns of GnRH Neurons
  66. The Relationship between Seminal Fluid Hyperviscosity and Oxidative Stress: A Systematic Review
  67. The Investigative Role of Statins in Ameliorating Lower Urinary Tract Symptoms (LUTS): A Systematic Review
  68. Differences in Penile Hemodynamic Profiles in Patients with Erectile Dysfunction and Anxiety
  69. Novel Insights on the Role of the Human Sperm Proteome
  70. Seminal Plasma Proteomic Biomarkers of Oxidative Stress
  71. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: scrotal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics
  72. Clinical Evaluation of a Custom Gene Panel as a Tool for Precision Male Infertility Diagnosis by Next-Generation Sequencing
  73. Seminal Plasma Transcriptome and Proteome: Towards a Molecular Approach in the Diagnosis of Idiopathic Male Infertility
  74. Effectiveness of a Very Low Calorie Ketogenic Diet on Testicular Function in Overweight/Obese Men
  75. Sexual Dysfunction in Diabetic Women: An Update on Current Knowledge
  76. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects
  77. Mean Platelet Volume as a Marker of Vasculogenic Erectile Dysfunction and Future Cardiovascular Risk
  78. Mitochondrial Membrane Potential Predicts 4-Hour Sperm Motility
  79. Erectile Dysfunction after Kidney Transplantation
  80. Follicle-Stimulating Hormone Treatment and Male Idiopathic Infertility: Effects on Sperm Parameters and Oxidative Stress Indices according to FSHR c. 2039 A/G and c. -29 G/A Genotypes
  81. Is There an Association Between Vitamin D Deficiency and Erectile Dysfunction? A Systematic Review and Meta-Analysis
  82. Use of Biosimilar Follicle-Stimulating Hormone in Asthenozoospermic Infertile Patients: A Multicentric Study
  83. D-Chiro-Inositol Improves Sperm Mitochondrial Membrane Potential: In Vitro Evidence
  84. The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: clinical, seminal and biochemical characteristics
  85. Sex-Specific SARS-CoV-2 Mortality: Among Hormone-Modulated ACE2 Expression, Risk of Venous Thromboembolism and Hypovitaminosis D
  86. Sperm Parameters before and after Swim-Up of a Second Ejaculate after a Short Period of Abstinence
  87. Disorders of Puberty: Endocrinology of the Pre-Pubertal Testis
  88. Is There a Role for Levo-Thyroxine for the Treatment of Arterial Erectile Dysfunction? The Clinical Relevance of the Mean Platelet Volume
  89. Molecular Biology of Spermatogenesis: Novel Targets of Apparently Idiopathic Male Infertility
  90. Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
  91. From Spermiogram to Bio-Functional Sperm Parameters: When and Why Request Them?
  92. Evaluation of Sperm Mitochondrial Function: A Key Organelle for Sperm Motility
  93. Coenzyme Q10 Improves Sperm Parameters, Oxidative Stress Markers and Sperm DNA Fragmentation in Infertile Patients with Idiopathic Oligoasthenozoospermia
  94. Evaluation of seminal fluid leukocyte subpopulations in patients with varicocele
  95. Combined Effects of the FSHR 2039 A/G and FSHR -29 G/A Polymorphisms on Male Reproductive Parameters
  96. Use of follicle‐stimulating hormone (FSH) for the male partner of idiopathic infertile couples in Italy: Results from a multicentre, observational, clinical practice survey
  97. Testicular Function of Childhood Cancer Survivors: Who Is Worse?
  98. Evaluation of the Mistakes in Self-Diagnosis of Sexual Dysfunctions in 11,000 Male Outpatients: A Real-Life Study in An Andrology Clinic
  99. Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
  100. Management and Treatment of Varicocele in Children and Adolescents: An Endocrinologic Perspective
  101. Effects of Insulin on Porcine Neonatal Sertoli Cell Responsiveness to FSH In Vitro
  102. Effects of GH and IGF1 on Basal and FSH-Modulated Porcine Sertoli Cells In-Vitro
  103. Accuracy of the Low-Dose ACTH Stimulation Test for Adrenal Insufficiency Diagnosis: A Re-Assessment of the Cut-Off Value
  104. Early male aging or poor clinical consideration for males in IVF centers? An original study
  105. Thyroid Hormones and Spermatozoa: In VitroEffects on Sperm Mitochondria, Viability and DNA Integrity
  106. Effects of the selective estrogen receptor modulators for the treatment of male infertility: a systematic review and meta-analysis
  107. Substance Abuse and Male Hypogonadism
  108. EAA clinical practice guidelines—gynecomastia evaluation and management
  109. Early Identification of Isolated Sertoli Cell Dysfunction in Prepubertal and Transition Age: Is It Time?
  110. Poor Efficacy of L-Acetylcarnitine in the Treatment of Asthenozoospermia in Patients with Type 1 Diabetes
  111. The IGF1 Receptor Is Involved in Follicle-Stimulating Hormone Signaling in Porcine Neonatal Sertoli Cells
  112. Environment and Male Fertility: Effects of Benzo-α-Pyrene and Resveratrol on Human Sperm Function In Vitro
  113. FSH therapy for idiopathic male infertility: four schemes are better than one
  114. IGF2 and IGF1R mRNAs Are Detectable in Human Spermatozoa
  115. Thyroid Prostate Axis. Does It Really Exist?
  116. Urogenital infections in patients with diabetes mellitus: Beyond the conventional aspects
  117. Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis
  118. Current and emerging medical therapeutic agents for idiopathic male infertility
  119. The advantages of proteomic investigation in the management of male accessory gland infection: A response to Grande et al
  120. Nicotine Receptors as a Possible Marker for Smoking-related Sperm Damage
  121. Epigenetics of Male Fertility: Effects on Assisted Reproductive Techniques
  122. Dual-release hydrocortisone treatment: glycometabolic profile and health-related quality of life
  123. IGF1 is involved in testicular differentiation and function
  124. Male accessory gland inflammation, infertility, and sexual dysfunctions: a practical approach to diagnosis and therapy
  125. Chromosome 15 structural abnormalities: effect on IGF1R gene expression and function
  126. The importance of the functional network between endothelial microparticles and late endothelial progenitor cells for understanding the physiological aspects of this new vascular repair system
  127. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution
  128. Conservative Nonhormonal Options for the Treatment of Male Infertility: Antibiotics, Anti-Inflammatory Drugs, and Antioxidants
  129. Chronic Administration of Tadalafil Improves the Symptoms of Patients with Amicrobic MAGI: An Open Study
  130. HumanPapilloma VirusInfection in Patients with Male Accessory Gland Infection: Usefulness of the Ultrasound Evaluation
  131. Asthenozoospermia and membrane remodeling enzymes: a new role for phospholipase A2
  132. In vitro effects of aspartic acid, coenzyme Q10 and zinc on sperm function
  133. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study
  134. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms
  135. Modulation of central glucocorticoid receptors in short- and long-term experimental hyperthyroidism
  136. Prevalence of Intratubular Germ Cell Neoplasia and Multifocality in Testicular Germ Cell Tumors ≤ 2 cm: Relationship With Other Pathological Features
  137. Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome
  138. Left spermatic vein retrograde sclerosis: comparison between sclerosant agent injection through a diagnostic catheter versus through an occluding balloon catheter
  139. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study
  140. Insulin Resistance Is an Independent Predictor of Severe Lower Urinary Tract Symptoms and of Erectile Dysfunction: Results from a Cross‐Sectional Study
  141. PARP-1 and CASP3 genes are up-regulated in LNCaP and PC-3 prostate cancer cell lines
  142. The gonadal function in obese adolescents: review
  143. PD25-09 NON ALCOHOLIC FATTY LIVER DISEASE IS AN INDEPENDENT PREDICTOR OF MODERATE-SEVERE LOWER URINARY TRACT SYMPTOMS IN METABOLIC SYNDROME PATIENTS: RESULTS FROM A CROSS-SECTIONAL STUDY
  144. PD25-06 INSULIN RESISTANCE IS SIGNIFICANTLY ASSOCIATED WITH SEVERITY OF LOWER URINARY TRACT SYMPTOMS AND WITH ERECTILE DYSFUNCTION: RESULTS FROM A CROSS-SECTIONAL STUDY
  145. New perspectives for prostate cancer treatment:in vitroinhibition of LNCaP and PC3 cell proliferation by amnion-derived mesenchymal stromal cells conditioned media
  146. Reduced Seminal Concentration of CD45pos Cells after Follicle-Stimulating Hormone Treatment in Selected Patients with Idiopathic Oligoasthenoteratozoospermia
  147. Association study of COX-2 (PTGS2) –765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer’s disease
  148. Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines
  149. CASP3 protein expression by flow cytometry in Down’s syndrome subjects
  150. Multifocality in testicular germ cell tumor (TGCT): what is the significance of this finding?
  151. Markers of semen inflammation: supplementary semen analysis?
  152. Erratum to: CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease
  153. CASP3 and LDOC-1 gene expression in a patient with carcinoma in the hairy part of the head skin and Alzheimer disease
  154. Male sexuality, fertility and smoking
  155. Endothelial progenitor cells and erectile dysfunction: a brief review on diagnostic significance and summary of our experience
  156. 1234 PREDICTIVE FACTORS OF ERECTILE DYSFUNCTION AFTER TURP IN POTENT PATIENTS
  157. Arterial erectile dysfunction: Different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil
  158. LDOC-1 and PARP-1 mRNA expression in leukocytes of father and son with cutaneous malignant melanoma
  159. Erratum to: Effects of experimentally induced hyperthyroidism on central hypothalamic–pituitary–adrenal axis function in rats: in vitro and in situ studies
  160. Best Practice Guidelines for the Use of Antioxidants in Male Infertility
  161. Best Practice Guidelines for the Use of Antioxidants
  162. Relationship between Testicular Volume and Conventional or Nonconventional Sperm Parameters
  163. Effects of Male Accessory Gland Infection on Sperm Parameters
  164. Does alcohol have any effect on male reproductive function? A review of literature
  165. Follicle-stimulating hormone treatment in normogonadotropic infertile men
  166. Persistence of ultrasound alterations after antibiotic treatment with levofloxacin in patients with male accessory gland infection
  167. Effects of experimentally induced hyperthyroidism on central hypothalamic–pituitary–adrenal axis function in rats: in vitro and in situ studies
  168. KIF21A mRNA expression in patients with Down syndrome
  169. P-429
  170. P-432
  171. P-431
  172. SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down’s syndrome and cryptorchidism
  173. Effects of short- and long-duration hypothyroidism on hypothalamic–pituitary–adrenal axis function in rats: In vitro and in situ studies
  174. Myoinositol: Does It Improve Sperm Mitochondrial Function and Sperm Motility?
  175. Two Proapoptotic Genes Are Downregulated in a Patient With Melanoma and Repeated In-Transit Metastases
  176. Prevalence ofUreaplasma urealyticumandMycoplasma hominisinfection in unselected infertile men
  177. Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome
  178. Best Practice Guidelines for the Use of Antioxidants
  179. Oxidative Stress and Infection
  180. Sperm DNA damage in patients with chronic viral C hepatitis
  181. Bone Demineralization in Postmenopausal Women: Role of Anamnestic Risk Factors
  182. Three apoptotic genes are upregulated in a patient with Alzheimer’s disease and well-differentiated squamous cell carcinoma
  183. Aerobic physical activity improves endothelial function in the middle-aged patients with erectile dysfunction
  184. Ultrasound characterization of the seminal vesicles in infertile patients with type 2 diabetes mellitus
  185. Seminal vesicles and diabetic neuropathy: ultrasound evaluation in patients with couple infertility and different levels of glycaemic control
  186. PARP1 and CASP3 gene expression in a patient with multiple head and neck squamous cell carcinoma and Parkinson disease
  187. High Frequency of Chronic Bacterial and Non-Inflammatory Prostatitis in Infertile Patients with Prostatitis Syndrome Plus Irritable Bowel Syndrome
  188. Over expression of LDOC1 and PARP1, two pro-apoptotic genes, in a patient with cryptorchidism and DiGeorge anomaly
  189. Original immunophenotype of blood endothelial progenitor cells and microparticles in patients with isolated arterial erectile dysfunction and late onset hypogonadism: effects of androgen replacement therapy
  190. Effects of Male Accessory Gland Infection on Sperm Parameters
  191. Chlamydia trachomatisPrevalence in Unselected Infertile Couples
  192. Endothelial Antioxidant Administration Ameliorates the Erectile Response to PDE5 Regardless of the Extension of the Atherosclerotic Process
  193. Oxidative stress and medical antioxidant treatment in male infertility
  194. Cigarette smoke extract immobilizes human spermatozoa and induces sperm apoptosis
  195. A High Percentage of Skin Melanoma Cells Expresses SPANX Proteins
  196. Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis
  197. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities
  198. Sexual Dysfunction in Chronic Hepatitis C Virus Patients Treated with Interferon Alpha and Ribavirin
  199. Transrectal ultrasonography in infertile patients with persistently elevated bacteriospermia
  200. SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Sicilian patients with melanoma
  201. Effects of Tumour Necrosis Factor-α on Human Sperm Motility and Apoptosis
  202. Effects of Tumour Necrosis Factor-α on Human Sperm Motility and Apoptosis
  203. Expression of SpanX mRNA in testicular germ cell tumors
  204. Quantitative evaluation of partial deletions of the DAZ gene cluster
  205. Expression of SpanX proteins in normal testes and in testicular germ cell tumours
  206. Gene expression in mouse spermatogenesis during ontogenesis
  207. Low total normal motile count values are associated with increased sperm disomy and diploidy rates in infertile patients
  208. Genetics of polycystic ovarian syndrome
  209. Human follicular fluid stimulates the sperm acrosome reaction by interacting with the γ-aminobutyric acid receptors
  210. Normal expression of isoforms activating cyclic adenosine monophosphate responsive element modulator in patients with spermatid maturation arrest
  211. Expression of SPANX proteins in human-ejaculated spermatozoa and sperm precursors
  212. Inhibition of oocyte fertilization by assisted reproductive techniques and increased sperm DNA fragmentation in the presence of Candida albicans: a case report
  213. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds
  214. Lower sperm aneuploidy rate is associated with a higher pregnancy rate in unselected patients undergoing intracytoplasmic sperm injection
  215. Chromosome analysis of epididymal and testicular spermatozoa in patients with azoospermia
  216. Gallbladder and gastric emptying: relationship to cholecystokininemia in diabetics
  217. Cloning and Expression of Activator of CREM in Testis in Human Testicular Tissue
  218. Genetic, andrological and clinical characteristics of patients with congenital bilateral absence of the vas deferens
  219. Increased ACTH and cortisol secretion after interleukin-1α injection in the common marmoset (Callithrix jacchus jacchus)
  220. Epididymal and testicular sperm retrieval in azoospermic patients and the outcome of intracytoplasmic sperm injection in relation to the etiology of azoospermia
  221. Effects of cancer and anti-neoplastic treatment on the human testicular function
  222. MACROPHAGE-DERIVED CYTOKINES IN THE FOLLICULAR FLUIDS OF WOMEN WITH INFERTILITY DUE TO IMMUNOLOGICAL CAUSES. ELEVATED LEVELS OF INTERLEUKIN 6 AND LOW LEVELS OF GRANULOCYTE–MACROPHAGE COLONY-STIMULATING FACTOR
  223. Mechanisms of Stress on Reproduction: Evidence for a Complex Intra-Hypothalamic Circuit
  224. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus
  225. Identification, Characterization, and Biological Activity of Endothelin Receptors in Human Ovary1
  226. The biobehavioral consequences of psychogenic stress in a small, social primate (Callithrix jacchus jacchus)
  227. Effects of Early Parenting on Growth and Development in a Small Primate
  228. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy
  229. Adenylate-Cyclase-Dependent Pituitary Adrenocorticotropin Secretion Is Defective in the Inflammatory-Disease-Susceptible Lewis Rat
  230. Effects of γ-aminobutyric acid on human sperm motility and hyperactivation
  231. Neurotransmitter Regulation of the Hypothalamic Corticotropin-Releasing Hormone Neuron
  232. Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer
  233. Effects of Rat Prolactin on Gonadotropin-Releasing Hormone Secretion by the Explanted Male Rat Hypothalamus
  234. Effects of Cholecystokinin Octapeptide on the Hypothalamic-Pituitary-Adrenal Axis Function and on Vasopressin, Prolactin and Growth Hormone Release in Humans
  235. Limited clinical usefulness of plasma corticotropin-releasing hormone, adrenocorticotropin and ß-endorphin measurements as markers of lung cancer.
  236. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery
  237. Effect of various neurotransmitters and neuropeptides on the release of corticotropin-releasing hormone from the rat cortex in vitro
  238. Neurotransmitter-lnduced Hypothalamic-Pituitary-Adrenal Axis Responsiveness Is Defective in Inflammatory Disease-Susceptible Lewis Rats: In vivo and in vitro Studies Suggesting Globally Defective Hypothalamic Secretion of Corticotropin-Releasing Hormone
  239. Effects of Short and Long Duration Hypothyroidism and Hyperthyroidism on the Plasma Adrenocorticotropin and Corticosterone Responses to Ovine Corticotropin-Releasing Hormone in Rats*
  240. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat
  241. Role of peripherally infused angiotensin II on the human hypothalamic–pituitary–adrenal axis
  242. Prolactin Stimulates Rat Hypothalamic Corticotropin-Releasing Hormone and Pituitary Adrenocorticotropin Secretion in vitro
  243. Circadian Patterns of Plasma Immunoreactive Corticotropin, Beta-Endorphin, Corticosterone and Prolactin after Immunoneutralization of Corticotropin-Releasing Hormone
  244. β-Endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopressin and direct pituitary action
  245. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH
  246. Recovery of the Rat Hypothalamic-Pituitary-Adrenal Axis after Discontinuation of Prolonged Treatment with the Synthetic Glucocorticoid Agonist Dexamethasone
  247. Interactions between Tumor Necrosis Factor-α, Hypothalamic Corticotropin-Releasing Hormone, and Adrenocorticotropin Secretion in the Rat*
  248. In Vitroandin VivoEffects of the Triazolobenzodiazepine Alprazolam on Hypothalamic Pituitary-Adrenal Function: Pharmacological and Clinical Implications*
  249. Mechanisms of Serotonin Receptor Agonist-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis in the Rat
  250. lntra- and Inter-Individual Variability in Growth Hormone Responses to Growth Hormone-Releasing Hormone
  251. Rat hypothalamic corticotropin-releasing hormone secretion is stimulated by interleukin-1 in an eicosanoid-dependent manner
  252. Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro
  253. The Muscarinic Cholinergic Agonist Arecoline Stimulates the Rat Hypothalamic-Pituitary-Adrenal Axis Through a Centrally-Mediated Corticotropin-Releasing Hormone-Dependent Mechanism
  254. The Alkyl-Ether Phospholipid Platelet-Activating Factor is a Stimulator of the Hypothalamic-Pituitary-Adrenal Axis in the Rat*
  255. Delayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphin
  256. Long-Term Cortisol Treatment Impairs Behavioral and Neuroendocrine Responses to 5-HT1 Agonists in the Rat
  257. Arachidonic Acid Metabolites Modulate Rat Hypothalamic Corticotropin-Releasing Hormone Secretion in vitro
  258. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone secretion by explanted rat hypothalami
  259. Sympathoadrenomedullary Inhibition by Chronic Glucocorticoid Treatment in Conscious Rats
  260. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro
  261. Interaction of Epidermal Growth Factor With the Hypothalamic-Pituitary-Adrenal Axis: Potential Physiologic Relevance*
  262. Effect of Cholinergic Agonists and Antagonists on Rat Hypothalamic Corticotropin-Releasing Hormone Secretion in vitro
  263. Dynamics of Plasma Gonadotropin and Sex Steroid Release in Polycystic Ovarian Disease After Pituitary Ovarian Inhibition with an Analog of Gonadotropin-Releasing Hormone*